Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ABBV Allergan Aesthetics to Acquire $SOLY - $22.60/share in cash
It's been demolished. It just shows how big the ups and downs can be with biotech stocks
CCXI getting hammered on FDA briefing docs
https://www.fda.gov/media/148176/download
ALDX achieves statistical significance https://finance.yahoo.com/news/aldeyra-therapeutics-achieves-statistical-significance-110000729.html
I bought in. Very exciting company
I like this one a lot. Strong revenues. Possible FDA approval for treosulfan (sp?) in august which could add another $150+ million in revenues plus nasdaq uplisting. Very undervalued
JNJ covid vaccine on pause https://endpts.com/us-pauses-jj-vaccinations-amid-new-reports-of-rare-serious-blood-clots/
No, i retracted my statement. The stock popped so it may be positive news. From what i have read on twitter, it may be a licensing deal
The stock shot higher after hours so maybe it’s good news
KZIA requests halt in trading until March 30. Should I assume it’s not good news they are going to release?
This is what makes it so concerning. So many irons in the fire for a few years and yet nothing has transpired. No updates on any progress with these programs and once again Mark will finish the quarter really empty handed. Have you noticed that often many of these deals and programs Mark has discussed over the years eventually disappear from his quarterly updates? AAV? Metabolites? Mitsubishi Tanabe? We don't really hear much about glyco engineering anymore
Anyone have an opinion on PAVM?
RHHBY $IONS Dosing to stop in Phase 3 clinical study of Tominersen following recommendation from an DMC
https://www.businesswire.com/news/home/20210322005754/en/
But why raise at somewhat low prices when you just received a large BARDA contract? This company is notorious at constantly raising
Cfrx raising at a crappy price. No surprise as they always and dilute shareholders but didn’t they just get a big barda contract? Why raise? Lol
Amazing things going on with this company. Aside from their dramatic growth and pending uplist to the Nasdaq, they have a great CEO who is on point and knows what he is doing and he is assembling a management team/board that is extremely impressive and will make sure the growth through acquisitions and organic growth is done right
Nothing in particular. You?
KDMN PDUFA extended from May 30th to August 30th
$AMGN acquires $FPRX $38 per share $XBI $IBB
VIR covid update, not good
https://finance.yahoo.com/news/vir-biotechnology-gsk-nih-sponsored-140000505.html
JNJ gets fda approval https://finance.yahoo.com/news/j-j-1-dose-shot-232220329.html
Thank you!
Gotcha. So then my ahac shares become part of the new company? And since the valuation of this new company is higher, I will then have less shares as it equates to the new valuation? Tia!
I’ve started my DD. Thank you for responding. Looks very exciting. Valuation seems low given the potential but seems somewhat far off from coming to market assuming success. I know it’s a SPAC so not exactly sure what happens to the ahac shares. Are they converted to a new company ?
Any thoughts on AHAC?